Navigation Links
Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

.3 percent). However, somnolence, sedation and fatigue typically occurred early in the study and most resolved as treatment continued. The incidence of syncopal events was less than 1 percent. In some of the patients who did experience syncope, potential contributing factors were noted (such as dehydration, sudden change in body position, and hot environment). While small changes in average blood pressure and pulse rate occurred, cardiovascular events were uncommon.

For all doses, the mean ADHD-RS-IV total scores and subscale scores showed significant improvement from baseline to endpoint: -18.1 points on the ADHD- RS-IV total; -8.5 points on the ADHD-RS-IV hyperactive/impulsive subscale and -9.5 points on the ADHD-RS-IV inattentive subscale (P <.001).

Similar to the 303 study, the objective of the 305 open-label trial was to assess the long-term safety and efficacy of GXR for the treatment of ADHD in children and adolescents aged 6 to 17 years. During the first month of this study, investigators made weekly adjustments as needed to each participants' once-daily GXR doses from 1 mg to 4 mg for optimal dosing, as defined by 30 percent or more improvement in ADHD-RS-IV total scores.

In this trial, the most commonly reported treatment emergent adverse events greater than 10 percent were somnolence (29.9 percent), headache (19.7 percent), upper respiratory tract infection (15.1 percent), fatigue (12.4 percent) and sedation (11.2 percent). The incidence of syncopal events was less than 2 percent. As in the 303 open-label study, potential contributing factors were noted in some of the patients who did experience syncope. No clinically relevant trends in ECGs, hematologic or laboratory parameters, vital signs, urinalyses, or physical examination were seen.

Interim results from trial 305 showed that for all doses, the mean ADHD- RS-IV total scores showed significant improvement of -21.6 points from baseline to endpoint (P <.001).

About Gua
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:9/29/2014)... -- Bob Pack, who lost his two young children to ... Association to immediately cease airing a television ad from ... News called "shamelessly deceptive" and of which the LA ... about the measure is wrong." The ... doctors check California,s existing statewide ...
(Date:9/29/2014)... 2014 Dynatronics Corporation (NASDAQ: ... investors today at 2:00 p.m. ET to discuss ... June 30, 2014.  The corrected call-in number for ... Dynatronics manufactures, markets and distributes advanced-technology medical ... and rehabilitation equipment for the physical therapy, sports ...
(Date:9/29/2014)... BOGOTA, Colombia , Sept. 29, 2014 /PRNewswire/ ... has announced a promising new drug treatment: ... 3-bromopyruvate (3-BrPA) that has already proven successful at ... medical researchers behind this novel treatment are optimistic ... patients who have exhausted current therapeutic avenues. ...
Breaking Medicine Technology:Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 2Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 3Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 4Father Calls On CA Medical Assn To Pull TV Ad Called "Jaw-Droppingly Deceptive" and "Baloney" By LA Times & "Shamelessly Deceptive" By San Jose Mercury News, Says Consumer Watchdog Campaign 5Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3
... Reportlinker.com announces that a new ... its catalogue: External ... Russia, India, China, South Africa) to ... External Defibrillator Market ...
... Orthopedic Group, Inc. today announced the appointment of Vinit ... immediately.  Mr. Asar joined the company in December 2008 ... nearly 20 years of global business operations experience in ... his new position, Mr. Asar will continue to lead ...
Cached Medicine Technology:External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18External Defibrillator Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 2Hanger Orthopedic Group Appoints Vinit K. Asar to President and Chief Operating Officer 3
(Date:9/30/2014)... SOLON, OH (PRWEB) September 30, 2014 ... wiper blades sporting the iconic pink ribbon in support ... October, a popular month for businesses and non-profits to ... this worthwhile cause. , AutoTex PINK is a woman-owned ... windshield wipers. They are committed to partnering with ...
(Date:9/30/2014)... 30, 2014 Loffler Companies, an ... technology and services was recognized by BEI as ... (FCE) in 2013. This prestigious rating means that ... time and for an extended period following, optimizing ... 20 years BEI Services has been the trusted ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Julie ... Hudson Allergy , will discuss how restaurants can ... and other special dietary restrictions at the 2014 ... Food Service Professionals, October 21 in New York City. ... incredibly important topic to such an engaged industry audience. ...
(Date:9/30/2014)... Up to 45% of the population snores ... have sleep apnea. Of these, only 10% have been ... tolerate their prescribed medical device known as CPAP (continuous ... which supports the airway during sleep. , In today’s ... and increasingly difficult to get. Snoring and sleep apnea ...
(Date:9/30/2014)... vitamin D3 compared with placebo did not reduce hospital ... stay, hospital mortality, or the risk of death at ... were critically ill, according to a study published in ... online to coincide with its presentation at the European ... A high prevalence of low vitamin D levels has ...
Breaking Medicine News(10 mins):Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 2Health News:Change Your Blades … Change A Life! AutoTex PINK Wiper Blades Are Helping Wipe Out Breast Cancer 3Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 2Health News:Loffler Companies Rated Number One Among U.S. Dealers in Service “First Call Effectiveness” 3Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 2Health News:Snoring: Robs People and Their Bed Partners of the Rest They Need to Face Daily Challenges 3Health News:High-dose vitamin D for ICU patients who are vitamin D deficient does not improve outcomes 2
... and an affordable follow-up test to identify children with ... first chemotherapy regimen, // has been developed by researchers ... have a good response may then be treated by ... ,This new test is based on testing ...
... center in Houston stated yesterday that ultrasound is fast becoming ... pregnant woman. // ,Dr. Wei Yang of ... to educate young women that the symptomatic breast cancer that ... pregnant, and so they should not wait to seek medical ...
... on a study to gauge if exercise can prevent ... after chemotherapy.// The study is being funded by a ... Armstrong. ,Charles Matthews, Ph.D., and Laurel Brown, ... lead a team of researchers at Vanderbilt-Ingram as they ...
... from the University of Alabama, Birmingham, told a jury at ... no significant difference in the rate of heart attacks //among ... drug Vioxx is produced and marketed by Merck & Co.'s. ... that the studies, covering a total of about 28,000 patients, ...
... that snake venom can be used for easing the debilitating ... development manager at the Shulov Institute of Sciences (SIS) in ... an analgesic based on snake venom could be on sale ... Palestinian viper - the most common snake in Israel - ...
... of an ambitious public-private initiative for the establishment of ... health professionals. // This announcement seeks to address the ... sections of the society. ,The new venture ... aims to impart multi-disciplinary knowledge through a network of ...
Cached Medicine News:Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 2Health News:Inexpensive ALL Follow-Up Test Developed By St. Jude Researchers 3Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: